Harmony Gets Dissonant US FDA Response For Wakix In Idiopathic Hypersomnia

refusing to file - 182843126 - shutterstock
The FDA refused to file a supplemental NDA for Wakix in excessive daytime sleepiness in adults with IH. • Source: Shutterstock

More from Review Pathways

More from Approval Standards